Financial Sense Advisors’s Quest Diagnostics DGX Stock Holding History

Financial Sense Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-20,552	Closed	-$1.89M	–	75
2016 Q4	$1.89M	Buy	20,552 +455	+2%	+$39.2K	1.2%	26
2016 Q3	$1.7M	Sell	20,097 -6,454	-24%	-$542K	1.11%	27
2016 Q2	$2.16M	Sell	26,551 -6,765	-20%	-$515K	1.21%	25
2016 Q1	$2.38M	Sell	33,316 -7,045	-17%	-$472K	1.38%	24
2015 Q4	$2.87M	Buy	40,361 +8,670	+27%	+$583K	1.34%	26
2015 Q3	$1.95M	Sell	31,691 -2,453	-7%	-$171K	1.35%	26
2015 Q2	$2.48M	Sell	34,144 -26,301	-44%	-$1.94M	1.15%	36
2015 Q1	$4.64M	Buy	60,445 +44,300	+274%	+$3.17M	1.94%	17
2014 Q4	$1.08M	Buy	+16,145	New	+$1.02M	0.44%	47

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Financial Sense Advisors's DGX Position: Q1 2017 in Review

Financial Sense Advisors sold out of Quest Diagnostics (DGX) in Q1 2017, closing a stake of 20,552 shares — an estimated $1.89M sold.

Financial Sense Advisors first reported a position in DGX in Q4 2014 and held it in 9 quarters. The position peaked at $4.64M in Q1 2015. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

Financial Sense Advisors reported no remaining Quest Diagnostics position as of Q1 2017 after selling out during the quarter.
Financial Sense Advisors sold 20,552 Quest Diagnostics shares in Q1 2017, an estimated $1.89M.
Financial Sense Advisors first reported a position in Quest Diagnostics in Q4 2014 and held it in 9 quarters.
Financial Sense Advisors's Quest Diagnostics position peaked at $4.64M in Q1 2015.
614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Financial Sense Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.